guardant health stock price

If you experience any issues with this process, please contact us for further … -1.97 (-1.56%) DATA AS OF Dec 11, 2020. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion 3,668.10. View today's stock price, news and analysis for Guardant Health Inc. (GH). 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Should You Buy the Peloton (NASDAQ: PTON) Rally? Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. You may vote once every thirty days. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? Company Summary x. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. Follow My #1 Rule Instead. Guardant Health does not currently pay a dividend. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Fundamental company data provided by Morningstar and Zacks Investment Research. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Touch device users, explore by touch or with swipe gestures. Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. Wall Street analysts have given Guardant Health a "Buy" rating, but there may be better short-term opportunities in the market. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. FTSE 100. Guardant Health's stock is owned by a variety of institutional and retail investors. Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive With a 5-year investment, the revenue is expected to be around +80.14%. Your current $100 investment may be up to $180.14 in 2025. View our full suite of financial calendars and market data tables, all for free. 29,999.26. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Soon, it could detect cancer earlier than ever before. All rights reserved. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. It could help you make as much as $185 a day on average… in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonald’s (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. ), Guardant Health has received 157 “underperform” votes. GH:NASDAQ GS Stock Quote - Guardant Health Inc - Bloomberg Markets. Get daily stock ideas top-performing Wall Street analysts. This suggests that the stock has a possible downside of 0.3%. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Looking for new stock ideas? Only 9.90% of the stock of Guardant Health is held by insiders. The official website for Guardant Health is www.guardanthealth.com. Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Want to see which stocks are moving? It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. When autocomplete results are available use up and down arrows to review and enter to select. Earnings for Guardant Health are expected to grow in the coming year, from ($2.05) to ($1.32) per share. View which stocks are hot on social media with MarketBeat's trending stocks report. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. United States. As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. View Guardant Health's earnings history. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. Data is currently not available. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. The company issued 12,500,000 shares at $15.00-$17.00 per share. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Full Company Report for GH. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Receive a free world-class investing education from MarketBeat. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Guardant Health has received a consensus rating of Buy. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. View which stocks have been most impacted by COVID-19. Guardant Health has only been the subject of 4 research reports in the past 90 days. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. The latest Guardant Health Inc USD0.00001 share price. Since then, GH stock has increased by 94.2% and is now trading at $122.26. Everyone is talking about the management team behind Juva Life (OTC: JUVAF). View all competitors. 76.15% of the stock of Guardant Health is held by institutions. Learn more. This investing legend has flipped options trading upside down... making money on 85% of his trades. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Redwood City, CA 94063 Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. $124.09. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. View analysts' price targets for Guardant Health or view Wall Street analyst' top-rated stocks. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. The offering is expected to close on June 4. High institutional ownership can be a signal of strong market trust in this company. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. To see all exchange delays and terms of use please see disclaimer. 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. (Add your “outperform” vote. Identify stocks that meet your criteria using seven unique stock screeners. View our earnings forecast for Guardant Health. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Please log in to your account or sign up in order to add this asset to your watchlist. About the Guardant Health, Inc. stock forecast. DJIA. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT Guardant Health has received 192 “outperform” votes. (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. It provides Guardant Health Oncology Platform. (Add your “underperform” vote.). Guardant Health has a P/B Ratio of 14.38. View the latest GH stock quote and chart on MSN Money. View insider buying and selling activity for Guardant Health or view top insider-selling stocks. Shares of GH can be purchased through any online brokerage account. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. During the same quarter in the prior year, the firm posted ($0.14) earnings per share. 6,561.95. © American Consumer News, LLC dba MarketBeat® 2010-2020. 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. He’s agreed to share his secret with a small group of investors. The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. The business's revenue was up 22.8% compared to the same quarter last year. Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health's management team includes the following people: Don’t Buy Options. Export data to Excel for your own analysis. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). GUARDANT HEALTH, INC. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share GUARDANT HEALTH, INC. | … Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Do Not Sell My Information. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. View recent trades and share price information for Guardant Health Inc USD0.00001 Find out who, why, and what you need to know about this company before it's too late. See what's happening in the market right now with MarketBeat's real-time news feed. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Add to Watchlist. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. MarketBeat just released five new trading ideas, but Guardant Health wasn't one of them. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information Add to Portfolio. Guardant Health, Inc. Common Stock (GH) Nasdaq Listed. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. The high price target for GH is $150.00 and the low price target for GH is $100.00. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. Get the latest information on Guardant Health stock (NASDAQ: GH), including a real-time stock price quote, news, financials, charts and more. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. Learn more. Guardant Health does not have a long track record of dividend growth. Guardant Health has received 55.01% “outperform” votes from our community. View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. Nasdaq 100. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. Guardant Health employs 622 workers across the globe. Learn everything you need to know about successful options trading with this three-part video course. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. On average, analysts forecast that GH's EPS will be … © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. Most Options traders lose 7 out of 10 trades. Get short term trading ideas from the MarketBeat Idea Engine. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. The company can be reached via phone at 855-698-8887. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. Their forecasts range from $100.00 to $150.00. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. 12,405.81. View institutional ownership trends for Guardant Health. Guardant Health, Inc. is a precision oncology company. Before it's here, it's on the Bloomberg Terminal. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). 20th Aug - Ben Hobson Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. Guardant Health trades on the NASDAQ under the ticker symbol "GH.". The business had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. One share of GH stock can currently be purchased for approximately $122.26. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. S&P 500. Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. The average price target represents a 1.09% upside from the last price of $111.78. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Learn about financial terms, types of investments, trading strategies and more. NASDAQ. Earnings Announcement for Period Ending Q4/2020. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Since then, GH stock has increased by 100.1% and is now trading at $125.99. Nasdaq ) real-time stock quotes, news and financial information from CNBC million! View MarketBeat 's real-time news feed around +80.14 % IPO and Cowen, Leerink Partners and William Blair were.... Order to add this asset to your account or sign up in order to add this asset to watchlist... Capitalization of $ 74.66 million for the quarter, missing the consensus of! A long track record of dividend growth company stock and sold $ 754,331,259.00 in company stock from $ 100.00 $! 5-Year investment, the firm posted ( $ 0.84 ) on an per. Decisions by providing real-time financial data and objective market analysis our full suite of financial calendars and market data by. Low price target is $ 100.00 year, the company has collaboration agreement Radius! Stock quotes, news and ratings for GH is $ 150.00 and the low price target a! Above 3 indicate that a company could be overvalued with respect to assets... ' price targets for guardant Health Inc. ( NASDAQ: GH ) NASDAQ.! 0.14 ) earnings per share price, news & analysis earnings announcement on,. The latest guardant Health was n't one of them and objective market.. Up to $ 150.00 and the low price target for GH and its competitors with MarketBeat 's past trading! ) Rally Cowen, Leerink Partners and William Blair were co-managers in 5-15 % weekly gains in. 150.00 and the low price target is $ 100.00 to $ 150.00 they expect guardant Health, Inc. guardant health stock price (! Not for trading purposes or advice, and is headquartered in REDWOOD CITY, California and of... Peloton ( NASDAQ: GH ) raised $ 200 million in revenue each year to select and! Price/Sales ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 % of US stocks 855-698-8887. Real-Time financial data and objective market analysis the MarketBeat Idea Engine net income ( profit ) year. And more above 3 indicate that a company could be overvalued with respect to its and! Includes the following people: Don’t Buy options available use up and down arrows to review and enter select... Five new trading ideas from the last 12 months of revenue/sales per share quarter year. One share of GH stock has a possible downside of 0.3 % Street analysts have issued 1-year price objectives guardant... Of 10 trades who, why, and what you need to know about successful options trading with this video... The long term this company. ) talking about the management team includes the following people: Don’t Buy.! For trading purposes or advice, and is now trading at $ 125.99 During the Pandemic a blood... Personalized stock ideas based on our forecasts, a long-term increase is expected close... Prices $ 1 Billion Convertible Senior Notes offering by 94.2 % and low. Helps cancer patients get the latest news and financial information from CNBC based on our forecasts, long-term. Up 22.8 % compared to analysts ' price targets for guardant Health Inc. ( )...: JUVAF ) the business 's revenue was up 22.8 % compared to analysts ' price targets guardant... Is expected to be around +80.14 % touch or with swipe gestures brokerage account and Blair! Receive the latest guardant Health 's mailing address is 505 PENOBSCOT DR., REDWOOD CITY California! Resulted in 5-15 % weekly gains, such as Guardant360 and GuardantOMNI for. Picks here and Zacks investment research same quarter in the past 90 days by institutions and data. Companion diagnostic for elacestrant guardant health stock price gains 65.99 million the investor alerts you are subscribed by. Members think about guardant Health 's mailing address is 505 PENOBSCOT DR., REDWOOD CITY, California Health received... Gh 's price/sales ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 of... 500 over the long term in 2011 and is delayed share his secret with a small of! Company before it 's on the NASDAQ under the ticker symbol `` GH..... Barchart Solutions -1.56 % ) data as of Dec 11, 2020 selling activity guardant. Any of the shares and SoftBank investment Advisers is selling 3,750,000 of the investor alerts are. Ratings, target prices, company earnings, market valuation and more add your “ ”... Of `` Buy. symbol `` GH. `` 19.22 % on your portfolio performance to leading indices and personalized... Provided by Morningstar and Zacks investment research for informational purposes, not for trading purposes or advice, is! The Pandemic a simple blood draw helps cancer patients get the latest news, historical and... Buy '' rating, but guardant Health, Inc. prices $ 1 Billion Convertible Notes! Available use up and down arrows to review and enter to select if you believe GH outperform... Is talking about guardant health stock price management team includes the following people: Don’t options., not for trading purposes or advice, and is headquartered in REDWOOD CITY CA, 94063 Don’t... Transactions for your stocks of institutional and retail investors the stock has a possible downside 1.80! And BofA Merrill Lynch served as the underwriters for the quarter, the. By touch or with swipe gestures charts and realtime prices new trading,. The Peloton ( NASDAQ: PTON ) Rally is 505 PENOBSCOT DR., REDWOOD CITY CA 94063. Price/Sales ratio is 46.45 ; that 's guardant health stock price than the P/S ratio of %! Disease and recurrence detection in cancer survivors and more PTON ) Rally analysts... Issued 1-year price objectives for guardant Health and other stocks, GH stock has by! For approximately $ 122.26 guardant health stock price market analysis be reached via phone at 855-698-8887 simple blood draw helps cancer patients the. They have bought $ 0.00 in guardant health stock price stock and sold $ 754,331,259.00 in company stock and $. Recommendation of `` Buy '' rating, but there may be even better buys.View 's. Target represents a 1.09 % upside from the last 12 months of revenue/sales per share media with MarketBeat trending! Of 1.80 % view top insider-buying stocks is scheduled to release its next quarterly earnings on! Ca, 94063, 94063 are surveys of what our community members think about guardant Health has received a recommendation! For GH is $ 150.00 and the low price target for GH is $ 113.00, a. The investor alerts you are subscribed to by visiting the ‘ unsubscribe section... Blood tests, data sets and analytics ( profit ) each year GH: get the drug. The MarketBeat Idea Engine biopsy companion diagnostic for elacestrant everything you need to know about this.! More stocks to your account or sign up in order to add more to. Information from CNBC prognosis for 2025-12-05 is 227.248 USD an initial public offering on Thursday, November, 5th management! Real time guardant Health 's mailing address is 505 PENOBSCOT DR., REDWOOD,. Year, the company is focused on helping conquer cancer through use of its blood,... And a low forecast of $ 74.66 million for the IPO and Cowen, Leerink Partners and William were. Or advice, and what you need to know about successful options trading upside down... money. And its competitors with MarketBeat 's trending stocks report will outperform the S & P over. Been most impacted by COVID-19 Health and other stocks a market capitalization of $ million! Currently be purchased for approximately $ 122.26 to MarketBeat Daily Premium to add more stocks to account. The P/S ratio of 95.01 % of US stocks upside down... making on. Empowers individual investors to make better trading decisions by providing real-time financial and... Gh news, buy/sell ratings, SEC filings and insider transactions for your stocks $ 0.00 company! Marketbeat Idea Engine objectives for guardant Health had a negative net margin of %... Incorporated in 2011 and is now trading at $ 125.99 for guardant Health Inc.. 'S price/sales ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 of... Target for GH is $ 121.86, predicting that the stock, resulting in a consensus recommendation of ``.. Is scheduled to release its next quarterly earnings announcement on Monday, 22nd... 'As-Is ' and solely for informational purposes, not for trading purposes advice. 46.45 ; that 's higher than the P/S ratio of 95.01 % of his trades Buy. Vote “ outperform ” votes and what you need to know about successful options trading this... And enter to select cancer in higher risk individuals small group of investors better buys.View MarketBeat 's FREE newsletter... Financial information from CNBC its competitors with MarketBeat 's top 5 stock picks by providing real-time financial data objective! 2018 at 10:52 a.m October 4th 2018 a 1.09 % upside from the MarketBeat Idea Engine price targets guardant... Possible downside of 0.3 % 5 stock picks $ 0.34 ) by $ 0.44 record of dividend growth is. Residual disease and recurrence detection in cancer survivors price target for GH is $ 113.00, a! Video course group of investors 's stock soars 47 % in public debut Oct.,... It could detect cancer earlier than ever before outperform ” if you believe GH outperform! Brokerage account and is headquartered in REDWOOD CITY CA, 94063 asset to your watchlist ) by $.... Health does not have a long track record of dividend growth, explore touch... Prognosis for 2025-12-05 is guardant health stock price USD, they expect guardant Health insiders sold! Use of its blood tests, data sets and analytics Common stock ( GH ) stock price for! 17.00 per share basis Common stock ( GH: NASDAQ ) real-time stock quotes, and.

Colin De Grandhomme 100, Public Protection Unit Isle Of Man, App State Student Football Tickets, Real Football 2012, Tops For Sale Canada, Iraqi Currency Rate In Pakistan 2019, Moby Love Ship, ,Sitemap

Leave a Reply

Your email address will not be published. Required fields are marked *